Q1: The study of effect of body on drug is called
(a) Pharmacology
(b) Pharmacodynamics
(c) Pharmacokinetics
(d) Pharmacotherapeutics
(e) Pharmacognosy
Answer ~ C
Q2: Which of the following route of administration has smallest bioavailability?
(a) Oral
(b) Intravenous
(c) Intramuscular
(d) Subcutaneous
(e) Topical
Q3: Which of the following route of administration has maximum bioavailability?
(a) Oral
(b) intravenous
(c) intramuscular
(d) subcutaneous
(e) Topical
Q4: Which of the following has slowest rate of absorption
(a) Inhalation
(b) Intramuscular
(c) Intravenous
(d) Oral
(e) Topical
Q5: First pass effect is due to the metabolism of drug in
(a) Portal circulation
(b) Gut wall
(c) Liver
(d) Kidney
(e) a,b&c
Q6: Distribution of the drug in body compartment is depend on
(a) organ size
(b) blood flow
(c) solubility
(d) binding
(e) A.O.T
Q7: Ratio of amount of drug in body to concentration in plasma is
(a) Relative volume of distribution
(b) Absolute volume of distribution
(c) Apparent valume of distribution
(d) comparative volume of distribution
(e) Bioavailability
Q8: A drug that activates its receptors upon binding is called
(a) Prodrug
(b) Placebo
(c) Antagonist
(d) Agonist
(e) Actual drug
Q9: Which of the following statement is correct regarding drugs?
(a) Act on living system at mollecular or chemical level
(b) are mostly weak base
(c) Majorty have mollecular weight between 100 to 1000
(d) Can be administered by both entral and parental route
(e) All of above
Q10: The main mechanism of most drug absorption in GI tract is
(a) Active transport( carrier mediated diffusion)
(b) Filteration (aqeous diffusion)
(c) Endocytosis and exocytosis
(d) Passive diffision (lipid diffusion)
(e) All of above
Q11: An agonist is a substance that:
(a) Interacts with receptors without producing an effect
(b) Interacts with receptors and initiates changes in cell
functions, producing various effects
(c) Increase conc: of another substance to produce effect
(d) Interacts with plasma protein and doesn’t produce an
effect
(e) Both b & c
Q12: If an agonist produce maximal effects and has high efficacy, it’s called;
(a) Partial agonist
(b) Antagonist
(c) Agonist-antagonist
(d) Full agonist
(e) Partial antagonist
Q13: If an agonist produce sub-maximal effects and has moderate efficay it is called;
(a) Partial agonist
(b) Antagonist
(c) Agonist-antagonist
(d) Full agonist
(e) Partial antagonist
Q14: Irreversible interaction of an antagonist with receptor is due to :
(a) Ionic bond
(b) Hydrogen bond
(c) Covalent bond
(d) Peptide bond
(e) All of the above
Q15: This the the following 2nd messanger of G-protein coupled (metabotropic) receptor :
(a) Adenyl cyclase
(b) Sodium ions
(c) Phospholipase C
(d) cAMP
(e) K ions
Q16: Which of the following substance which changes the activity of an effector element but doesn’t belong to 2nd messengers;
(a) cAMP
(b) cGMP
(c) G protein
(d) Ca++ ions
(e) K ions
Q17: Conjugation of the drug includes the following except;
(a) Glucuronidation
(b) Sulfation
(c) Hydrolysis
(d) Methylation
(e) both b&c
Q18: In case of liver disorders accompanied by a decline in microsomal enzyme activity, the duration of action of some drug ;
(a) Decreased
(b) Enlarged
(c) Reamin unchanged
(d) changed insignificantly
(e) First increase then decrease
Q19: Half life doesn’t depend on;
(a) Biotranformation
(b) Time of drug absorption
(c) concentration of drug in plasma
(d) Rate of drug elimination
(e) None of above
Q20: Pharmacodynamics involves the study of following except :
(a) Biological & therapeutic effect of drugs
(b) Absorption & distribution of drugs
(c) Mechanism of drug action
(d) Drug interaction
(e) All are correct
Q21: What does affinity means?
(a) A measure of how tightly a drug binds to plasma protein
(b) A measure of how tightly a drug binds to a receptor
(c) A measure of inhibiting potency of drug
(d) A measure of bioavailability of drug
(e) A measure of elimination of drug
Q22: Two drugs with the same effect given together produce an effect that us greater than sum of effects of drugs given individually is;
(a) Addition
(b) Synergism
(c) potentiation
(d) Multiplication
(e) subtraction
Q23: Constant amount of drug is metabolised per unit time in —— order elimination;
(a) 1st
(b) 2nd
(c) 3rd
(d) Zero
(e) None of above
Q24: Safety of a drug can be estimated by;
(a) Therapeutic index
(b) Graded dose response curve
(c) Potency
(d) efficacy
(e) quantal dose response curve
Q25: Metabolic tranformation (phase 1)
(a) Acetylation & methylation of substance
(b) Tranformation of substance due to oxidation,
reduction or hydrolysis
(c) Glucuronide formation
(d) Binding to plasma protein
(e) All of them
Answer ~ B
Q26: Biotranformation of a medicinal substance results in;
(a) Faster urinary excreation
(b) Slower urinary excreation
(c) Easier distribution in organism
(d) Higher binding to membranes
(e) No excreation
Answer ~ A
Q27: Conjugation is:
(a) Process of drug reduction by special enzymes
(b) Process of drug oxidation by special enzyme
(c) Coupling of a drug with an endogenous substrate
(d) Solubilization in lipids
(e) All of them
Answer ~ C
Q28: Which of the following process processes proceeds in the 2nd phase of tranformation?
(a) Acetylation
(b) Reduction
(c) Oxidation
(d) Hydrolysis
(e) Redox
Answer ~ A
Q29. Most drugs gain entry to cells by:
(a) Passive diffusion with zero order kinetics
(b) Passive diffusion with first order kinetics
(c) Active diffusion with zero order kinetics
(d) Active diffusion with first order kinetics
(e) Passive diffusion through membrane pores
Answer ~ B
Q30: Which of the following is a phase 2 metabolism reaction associated with genetic polymorphism?
(a) Acetylation
(b) Glucuronidation
(c) Oxidation
(d) Reduction
(e) Glutathione conjugation
Answer~ A
